A novel stratification framework for predicting outcome in patients with prostate cancer

Luca, Bogdan, Moulton, Vincent ORCID: https://orcid.org/0000-0001-9371-6435, Ellis, Christopher, Edwards, Dylan R. ORCID: https://orcid.org/0000-0002-3292-2064, Campbell, Colin, Cooper, Rosalin A., Clark, Jeremy, Brewer, Daniel S. ORCID: https://orcid.org/0000-0003-4753-9794 and Cooper, Colin S. ORCID: https://orcid.org/0000-0003-2013-8042 (2020) A novel stratification framework for predicting outcome in patients with prostate cancer. British Journal of Cancer, 122 (10). 1467–1476. ISSN 0007-0920

	Microsoft Excel (OpenXML) (Supp_Data_3) - Accepted Version Download (17kB)
	Microsoft Excel (OpenXML) (Supp_Data_2) - Accepted Version Download (28kB)
	Microsoft Excel (OpenXML) (Supp_Data_1) - Accepted Version Download (34kB)
	Microsoft Word (OpenXML) (Supplementary_material) - Accepted Version Download (6MB)
Preview	PDF (BJC_VoR) - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview
Preview	PDF (Accepted_Manuscript) - Accepted Version Download (965kB) | Preview

Abstract

Background: Unsupervised learning methods, such as Hierarchical Cluster Analysis, are commonly used for the analysis of genomic platform data. Unfortunately, such approaches ignore the well-documented heterogeneous composition of prostate cancer samples. Our aim is to use more sophisticated analytical approaches to deconvolute the structure of prostate cancer transcriptome data, providing novel clinically actionable information for this disease. Methods: We apply an unsupervised model called Latent Process Decomposition (LPD), which can handle heterogeneity within individual cancer samples, to genome-wide expression data from eight prostate cancer clinical series, including 1,785 malignant samples with the clinical endpoints of PSA failure and metastasis. Results: We show that PSA failure is correlated with the level of an expression signature called DESNT (HR = 1.52, 95% CI = [1.36, 1.7], P = 9.0 × 10 −14, Cox model), and that patients with a majority DESNT signature have an increased metastatic risk (X 2 test, P = 0.0017, and P = 0.0019). In addition, we develop a stratification framework that incorporates DESNT and identifies three novel molecular subtypes of prostate cancer. Conclusions: These results highlight the importance of using more complex approaches for the analysis of genomic data, may assist drug targeting, and have allowed the construction of a nomogram combining DESNT with other clinical factors for use in clinical management.

Item Type:	Article
Uncontrolled Keywords:	breast,erg,gene-expression,genomic classifier,heterogeneity,high-risk,identification,integration,radical prostatectomy,validation,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Computing Sciences
UEA Research Groups:	Faculty of Science > Research Groups > Computational Biology Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	12 Feb 2020 05:38
Last Modified:	19 Oct 2023 02:38
URI:	https://ueaeprints.uea.ac.uk/id/eprint/74155
DOI:	10.1038/s41416-020-0799-5

Downloads

Actions (login required)

View Item